VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Long until 2025

<< Previous

Bullboard Posts

Next >>

Comment by shawshank666on Oct 27, 2023 9:24am

43 Views

Post# 35703779

RE:RE:Long until 2025

I really like this statement. And Alvira said there has been 3-4 demos per month so there are 3-4 sales per month. We have nothing to worry about!!! 3-4 sales per month or 36-48 per year. Let's see when the third quarter and year-end results are out.
Statements of 4000 leads, 100% conversions of demos-yet the facts dont suppport it

<< Previous

Bullboard Posts

Next >>

Mid-year update: Charting GameSquare’s sharp business growth